Course:PHAR451/Erectile Dysfunction
Erectile Dysfunction | |
---|---|
PHAR 451 | |
Section: | |
Instructor: | Ms. Wynnie Lau |
Email: | lau.wynnie@alumni.ubc.ca |
Office: | |
Office Hours: | |
Class Schedule: | |
Classroom: | PHRM 1101 |
Important Course Pages | |
Syllabus | |
Lecture Notes | |
Assignments | |
Course Discussion | |
Erectile Dysfunction
Updated: October 21st, 2013
Instructor
Ms. Wynnie Lau
lau.wynnie@alumni.ubc.ca
Pre-Session Objectives
PRIOR TO arriving at the session, participants should be able to
- Have a general understanding of the risk factors associated with Erectile Dysfunction
- Know two different classes of medications used in the treatment of Erectile Dysfunction and list one medication in each class
Preparation for the session
- Read corresponding chapter in Therapeutic Choices about Male Sexual Dysfunction
By the end of the session, and upon study and reflection, students should be able to
- Discuss the common causes of erectile dysfunction
- Identify medications that can lead to erectile dysfunction
- List therapies to treat erectile dysfunction and be able to discuss them in terms of: mechanism of action, adverse effects, drug interactions & contraindications, clinical efficacy and patient counselling
Supportive Literature & Further Reading
- Andersson K-E. Pharmacology of Penile erection. Pharmacol Rev 2001; 53:417-50.
- Corona G et al. Sexual function of the aging male. Best practice & research clinical endocrinology and metabolism 2013;27:581-601.
- Costa Pierre and Potempa AJ. Intraurethral alprostadil for erectile dysfunction. Drugs 2012; 72(17):2243-54.
- Jannini EA et al. Which is First? The controversial issue of precedence in the treatment of male sexual dysfunction. J Sex MEd 2013; 10:2359-2369.
- Yuan JQ et al. European Urology 2013;63:902-12.
- Wespes E et al. EU Guidelines on Male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Association of Eur 2013.
- Porst H et al. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo controlled, clinical studies. Eur Urology. Published online ahead of print 2 Oct 2013.
- Tsertsvadze A et al. Oral phosphodiesterase - 5 inhibitors and hormonal treatments for erectile dysfunction: Systematic review and meta-analysis. Ann Intern Med 2009; 151:650-61.